Julie Hambleton has an estimated net worth of $1.52 Million. This is based on reported shares across multiple companies, which include Erasca, Inc., IGM Biosciences, Inc., IDEAYA Biosciences, Inc., SpringWorks Therapeutics, Inc., and FIVE PRIME THERAPEUTICS INC.

2015 was Julie Hambleton's most active year for acquiring shares with 5 total transactions. Julie Hambleton's most active month to acquire stocks was the month of April. 2025 was Julie Hambleton's most active year for disposing of shares, totalling 7 transactions. Julie Hambleton's most active month to dispose stocks was the month of June. 2025 saw Julie Hambleton paying a total of $444,486.98 for 143,834 shares, this is the most they've acquired in one year. In 2025 Julie Hambleton cashed out on 85,905 shares for a total of $730,206.57, their largest year based on trade value.